These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37561337)

  • 1. Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments.
    Orji NC; Cox IA; Jason LA; Chen G; Zhao T; Rogerson MJ; Kelly RM; Wills K; Hensher M; Palmer AJ; de Graaff B; Campbell JA
    Qual Life Res; 2024 Jan; 33(1):45-57. PubMed ID: 37561337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.
    Campbell JA; Ahmad H; Chen G; van der Mei I; Taylor BV; Claflin S; Henson GJ; Simpson-Yap S; Laslett LL; Hawkes K; Hurst C; Waugh H; Palmer AJ
    Qual Life Res; 2023 Feb; 32(2):553-568. PubMed ID: 36036311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models.
    Ahmad H; Campbell JA; van der Mei I; Taylor BV; Xia Q; Zhao T; Palmer AJ
    Qual Life Res; 2023 Dec; 32(12):3373-3387. PubMed ID: 37522942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
    Cox IA; Campbell J; de Graaff B; Otahal P; Corte TJ; Moodley Y; Hopkins P; Macansh S; Walters EH; Palmer AJ
    Qual Life Res; 2023 Feb; 32(2):473-493. PubMed ID: 35927542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.
    Campbell JA; Palmer AJ; Venn A; Sharman M; Otahal P; Neil A
    Patient; 2016 Aug; 9(4):311-22. PubMed ID: 26841910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery.
    Campbell JA; Hensher M; Neil A; Venn A; Otahal P; Wilkinson S; Palmer AJ
    Pharmacoecon Open; 2018 Dec; 2(4):443-458. PubMed ID: 29623636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating health-related quality of life and subjective wellbeing among infertility patients: a cross-sectional study in mainland China.
    Shi Z; Nie H; Geng L; Wang X; Chen G; Li S
    Qual Life Res; 2023 May; 32(5):1469-1480. PubMed ID: 36617607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.
    Claflin S; Campbell JA; Norman R; Mason DF; Kalincik T; Simpson-Yap S; Butzkueven H; Carroll WM; Palmer AJ; Blizzard CL; van der Mei I; Henson GJ; Taylor BV
    Eur J Health Econ; 2023 Aug; 24(6):939-950. PubMed ID: 36149605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia.
    Chan HY; Wijnen BFM; Hiligsmann M; Smit F; Leenen LAM; Majoie MHJM; Evers SMAA
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jul; 22(5):795-803. PubMed ID: 34553651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Exploratory Study of Long-Term Publicly Waitlisted Bariatric Surgery Patients' Quality of Life Before and 1 Year After Bariatric Surgery, and Considerations for Healthcare Planners.
    Campbell JA; Hensher M; Neil A; Venn A; Wilkinson S; Palmer AJ
    Pharmacoecon Open; 2018 Mar; 2(1):63-76. PubMed ID: 29464671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of depression on health-related quality of life and wellbeing: identifying important dimensions and assessing their inclusion in multi-attribute utility instruments.
    Engel L; Chen G; Richardson J; Mihalopoulos C
    Qual Life Res; 2018 Nov; 27(11):2873-2884. PubMed ID: 30006664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feelings of depression, pain and walking difficulties have the largest impact on the quality of life of people with multiple sclerosis, irrespective of clinical phenotype.
    Zhang Y; Taylor BV; Simpson S; Blizzard L; Campbell JA; Palmer AJ; van der Mei I
    Mult Scler; 2021 Jul; 27(8):1262-1275. PubMed ID: 32924841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS).
    Falk Hvidberg M; Brinth LS; Olesen AV; Petersen KD; Ehlers L
    PLoS One; 2015; 10(7):e0132421. PubMed ID: 26147503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the reliability of a novel cancer-specific multi-attribute utility instrument (FACT-8D) and comparing its validity to EQ-5D-5L in colorectal cancer patients.
    Cao Y; Zhang H; Luo N; Li H; Cheng LJ; Huang W
    Qual Life Res; 2024 Dec; 33(12):3309-3322. PubMed ID: 39225938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framing of mobility items: a source of poor agreement between preference-based health-related quality of life instruments in a population of individuals receiving assisted ventilation.
    Hannan LM; Whitehurst DGT; Bryan S; Road JD; McDonald CF; Berlowitz DJ; Howard ME
    Qual Life Res; 2017 Jun; 26(6):1493-1505. PubMed ID: 28255744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China.
    Ding N; Zhou H; Chen C; Chen H; Shi Y
    Appl Health Econ Health Policy; 2024 Jul; 22(4):555-568. PubMed ID: 38641755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian population norms for health-related quality of life measured using the EQ-5D-5L, and relationships with sociodemographic characteristics.
    Redwood L; Currow D; Kochovska S; Thomas SJ
    Qual Life Res; 2024 Mar; 33(3):721-733. PubMed ID: 38085452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia.
    Pan T; Wu Y; Buchanan J; Goranitis I
    Health Qual Life Outcomes; 2023 Dec; 21(1):132. PubMed ID: 38087302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma.
    Dieng M; Kasparian NA; Cust AE; Costa DSJ; Tran A; Butow PN; Menzies SW; Mann GJ; Morton RL
    JAMA Dermatol; 2018 Jan; 154(1):52-59. PubMed ID: 29188268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.